#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10758	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2013	527.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1682	1682	T	573	T,C	543,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10758	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2013	527.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	671	C	649	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10758	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2013	527.0	0	HET	.	.	.	C1370T	.	1370	1370	C	1602	1602	C	662	C,T	482,168	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20094	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3739	535.3	0	.	n	.	0	T695C	SNP	695	695	T	1023	1023	C	617	C	601	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20094	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3739	535.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1665	1665	A	642	A,G	633,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20094	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3739	535.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2299	2299	C	615	C,T,A,G	590,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20094	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3739	535.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2373	2373	A	630	A	619	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20094	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3739	535.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2925	2925	C	580	C	561	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20094	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3739	535.3	0	HET	.	.	.	C2849T	.	2849	2849	C	3177	3177	C	635	C,T	475,143	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	10	blaTEM	861	166	98.8	blaTEM.l15.c30.ctg.1	270	1.7	0	.	p	.	0	P12S	NONSYN	34	36	CCC	138	140	TCC	1;1;1	T;C;C	1;1;1	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	10	blaTEM	861	166	98.8	blaTEM.l15.c30.ctg.1	270	1.7	0	.	p	.	0	K32R	NONSYN	94	96	AAA	198	200	AGA	2;2;3	A;G,A;A	2;0,2;2	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1502	folP	855	855	100.0	folP.l15.c4.ctg.1	1503	99.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1019	1021	AGC	149;150;152	A;G;C	146;148;148	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4294	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	127.4	1	SNP	p	S91F	1	.	.	271	273	TTC	561	563	TTC	145;146;147	T;T;C	140;142;139	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4294	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	127.4	1	SNP	p	D95G	1	.	.	283	285	GGC	573	575	GGC	147;146;146	G;G;C	141;142;141	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4294	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	127.4	1	SNP	p	G95N	0	.	.	283	285	GGC	573	575	GGC	147;146;146	G;G;C	141;142;141	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1274	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1381	91.7	1	SNP	p	G45D	0	.	.	133	135	GGC	496	498	GGC	147;147;149	G,C;G,A;C	142,1;141,1;143	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	632	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	956	65.7	0	.	n	.	0	A197.	DEL	197	197	A	571	571	A	140	A	133	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3522	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3009	116.4	1	SNP	p	D86N	0	.	.	256	258	GAC	550	552	GAC	128;127;126	G;A;C	121;116;125	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3522	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3009	116.4	1	SNP	p	R87W	0	.	.	259	261	CGT	553	555	CGT	126;124;126	C,A;G;T	122,1;122;121	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3522	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3009	116.4	1	SNP	p	R87I	0	.	.	259	261	CGT	553	555	CGT	126;124;126	C,A;G;T	122,1;122;121	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3522	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3009	116.4	1	SNP	p	S87R	1	.	.	259	261	CGT	553	555	CGT	126;124;126	C,A;G;T	122,1;122;121	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3522	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3009	116.4	1	SNP	p	S88P	0	.	.	262	264	TCC	556	558	TCC	127;129;127	T;C,G;C	125;125,1;124	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3086	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2583	118.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1524	1526	GGC	154;151;150	G;G,A;C	151;146,1;145	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1263	1265	GCA	163;164;165	G;C,A;A	153;155,1;159	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1266	1268	ATC	167;167;167	A;T;C	162;162;161	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1278	1280	GTG	166;163;163	G;T;G	162;157;160	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1278	1280	GTG	166;163;163	G;T;G	162;157;160	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1782	1784	ACC	132;131;129	A;C;C	127;128;126	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1836	1838	GCG	124;122;122	G;C,G;G	119;102,2;113	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1836	1838	GCG	124;122;122	G;C,G;G	119;102,2;113	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1959	1961	AGC	127;128;128	A;G;C	119;122;120	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1968	1970	GGC	118;117;117	G;G;C	113;111;112	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2700	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2385	112.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1986	1988	CCG	90;90;88	C,G;C,G;G	83,1;83,1;82	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	4138	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	2958	138.7	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1396	1398	ACG	152;150;150	A,G,C;C;G	144,1,1;145;147	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	4138	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	2958	138.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1534	1536	CCG	145;144;141	C;C,T;G	135;134,1;136	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1818	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1810	99.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	611	611	C	135	C	126	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	380	382	GAA	151;148;151	G;A;A	147;143;148	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	668	670	GAT	154;154;155	G,T;A;T	148,1;150;150	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	791	793	TCA	123;126;127	T;C;A	121;123;122	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	920	922	GTC	152;152;153	G;T;C	149;149;150	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	0	.	p	.	0	F222S	NONSYN	664	666	TTT	932	934	TCT	158;158;160	T;C;T	155;157;159	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1250	1252	GCA	150;146;150	G;C,A;A	148;143,1;147	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	1	SNP	p	G120K	1	.	.	358	360	AAG	626	628	AAG	155;155;158	A;A;G	153;154;155	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	1	SNP	p	D121N	0	.	.	361	363	GAC	629	631	GAC	157;154;154	G;A;C	155;149;150	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1920	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1444	129.9	1	SNP	p	A121D	1	.	.	361	363	GAC	629	631	GAC	157;154;154	G;A;C	155;149;150	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6776	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4930	137.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	828	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1119	73.6	1	SNP	p	V57M	1	.	.	169	171	ATG	575	577	ATG	148;148;145	A;T;G	144;140;139	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
